Washburn Therapeutics, Inc. is developing gels for locally controlling inflammation. Based on technology licensed from Carnegie Mellon University, these gels will be used to treat a broad range of injuries and disease states.

For more information, contact:
Newell Washburn, President
412-908-1309
newell@washburntherapeutics.com